US Stock MarketDetailed Quotes
EYESW Second Sight Medical Products Inc C/Wts 14/03/2024(To Pur Com) R/S
- 0.0000
- 0.00000.00%
Close Aug 23 09:30 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.219852wk High0.00P/B0Float Cap0.190052wk Low--Dividend TTM0Shs Float13.2800Historical High--Div YieldTTM0.00%Amplitude0.0250Historical Low--Avg Price1Lot Size
Second Sight Medical Products Inc C/Wts 14/03/2024(To Pur Com) R/S Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 23.01%-3.22M | -153.86%-1.98M | 45.38%-9.19M | -66.90%-2.43M | -21.79%-1.8M | 20.09%-4.19M | 91.01%-778K | 39.11%-16.82M | 80.33%-1.45M | 77.11%-1.48M |
| Net income from continuing operations | -34.09%-3.08M | 22.19%-2.21M | 40.05%-8.92M | 0.62%-1.28M | -56.02%-2.5M | 26.00%-2.29M | 68.01%-2.84M | 55.70%-14.88M | 83.59%-1.29M | 78.86%-1.6M |
| Depreciation and amortization | -21.05%15K | -20.00%16K | -57.32%70K | -18.75%13K | -18.18%18K | -5.00%19K | -81.13%20K | -58.69%164K | -84.62%16K | -77.32%22K |
| Other non cash items | -33.33%-4K | -62.50%6K | -99.26%9K | -102.04%-2K | -300.00%-2K | ---3K | -98.57%16K | -53.26%1.22M | 2,350.00%98K | -66.67%1K |
| Change In working capital | 91.17%-170K | -89.95%202K | 88.76%-421K | -286.47%-1.17M | 788.00%666K | 14.21%-1.93M | 258.14%2.01M | -10,218.92%-3.74M | 66.37%-303K | -89.08%75K |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 860.42%461K | --0 | --0 |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 252.45%529K | 158.35%311K | -34.18%362K |
| -Change in prepaid assets | 53.72%-392K | -8.13%305K | 121.40%168K | 226.27%274K | 300.49%409K | -444.31%-847K | 154.43%332K | -173.36%-785K | -461.67%-217K | -148.00%-204K |
| -Change in payables and accrued expense | 104.12%53K | -91.77%136K | 18.39%-1.16M | -594.42%-1.62M | 197.83%90K | 32.58%-1.29M | 104.20%1.65M | -56.42%-1.43M | 7.54%-233K | 89.86%-92K |
| -Change in other working capital | -18.75%169K | -1,019.23%-239K | 122.74%574K | 205.49%173K | 1,755.56%167K | 137.41%208K | 101.43%26K | -1,525.99%-2.52M | -1,125.00%-164K | -96.50%9K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 23.01%-3.22M | -153.86%-1.98M | 45.38%-9.19M | -66.90%-2.43M | -21.79%-1.8M | 20.09%-4.19M | 91.01%-778K | 39.11%-16.82M | 80.33%-1.45M | 77.11%-1.48M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -8.02M | -120.59%-14K | -1,500.00%-14K | 0 | 0 | 0 | 113.79%68K | 101.01%1K | 273.04%398K |
| Net PPE purchase and sale | --0 | ---18K | 95.76%-14K | -1,500.00%-14K | --0 | --0 | --0 | 33.06%-330K | 101.01%1K | --0 |
| Net other investing changes | --0 | ---8M | ---- | ---- | ---- | ---- | ---- | --398K | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---8.02M | -120.59%-14K | -1,500.00%-14K | --0 | --0 | --0 | 113.79%68K | 101.01%1K | 273.04%398K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 779.44%75.61M | 0 | 0 | 698.81%51.15M | 489,420.00%24.47M | -75.43%8.6M | 525.00%2.2M | 0 |
| Net issuance payments of debt | ---- | ---- | -200.00%-2.2M | --0 | --0 | ---- | ---- | --2.2M | --2.2M | --0 |
| Net common stock issuance | ---- | ---- | 1,064.68%77.79M | ---25K | ---- | ---- | ---- | -80.64%6.68M | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | 108.90%25K | --25K | ---77.81M | --53.35M | --24.47M | -158.06%-281K | --0 | --0 |
| Net other financing activities | ---- | ---- | --2K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | 779.46%75.62M | -99.91%2K | --0 | 698.81%51.15M | 489,420.00%24.47M | -75.43%8.6M | 525.00%2.2M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 121.87%59.6M | 2,090.53%69.59M | -71.95%3.18M | 2,855.60%72.03M | 2,006.85%73.85M | 1,048.44%26.86M | -71.95%3.18M | 153.34%11.33M | -86.80%2.44M | -86.07%3.51M |
| Current changes in cash | -106.86%-3.22M | -142.19%-9.99M | 914.30%66.41M | -425.80%-2.44M | -66.67%-1.8M | 3,927.70%46.96M | 363.49%23.69M | -218.77%-8.16M | 110.49%748K | 83.85%-1.08M |
| Effect of exchange rate changes | --0 | 66.67%-1K | -66.67%2K | 125.00%2K | -241.67%-17K | --20K | -250.00%-3K | 154.55%6K | -300.00%-8K | 209.09%12K |
| End cash Position | -23.65%56.38M | 121.87%59.6M | 2,090.53%69.59M | 2,090.53%69.59M | 2,855.60%72.03M | 2,006.85%73.85M | 1,048.44%26.86M | -71.95%3.18M | -71.95%3.18M | -86.80%2.44M |
| Free cash flow | 23.01%-3.22M | -156.17%-1.99M | 46.35%-9.2M | -67.98%-2.44M | -21.79%-1.8M | 20.09%-4.19M | 91.34%-778K | 39.01%-17.15M | 80.60%-1.45M | 77.90%-1.48M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg